Evidence map›Paper›PMID 30753093›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2019

Neuroprotective effect of placenta-derived mesenchymal stromal cells: role of exosomes.

Priyadarsini Kumar, James C Becker, Kewa Gao, Randy P Carney, Lee Lankford, Benjamin A Keller, Kyle Herout, Kit S Lam, Diana L Farmer, Aijun Wang

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Hydrogel-based neural engineering for skin wound healing.Frontiers in cell and developmental biology · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Serum exosomal coronin 1A and dynamin 2 as neural tube defect biomarkers.Journal of molecular medicine (Berlin, Germany) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Priyadarsini KumarSurgical Bioengineering Laboratory, Department of Surgery, University of California-Davis, Sacramento, California, USA.
James C BeckerSurgical Bioengineering Laboratory, Department of Surgery, University of California-Davis, Sacramento, California, USA.
Kewa GaoSurgical Bioengineering Laboratory, Department of Surgery, University of California-Davis, Sacramento, California, USA.
Randy P CarneyDepartment of Biomedical Engineering, University of California-Davis, Davis, California, USA.
Lee LankfordSurgical Bioengineering Laboratory, Department of Surgery, University of California-Davis, Sacramento, California, USA.
Benjamin A KellerSurgical Bioengineering Laboratory, Department of Surgery, University of California-Davis, Sacramento, California, USA.
Kyle HeroutSurgical Bioengineering Laboratory, Department of Surgery, University of California-Davis, Sacramento, California, USA.
Kit S LamDepartment of Biochemistry and Molecular Medicine, School of Medicine, University of California-Davis, Sacramento, California, USA.
Diana L FarmerSurgical Bioengineering Laboratory, Department of Surgery, University of California-Davis, Sacramento, California, USA.
Aijun WangSurgical Bioengineering Laboratory, Department of Surgery, University of California-Davis, Sacramento, California, USA.
University of California, Davis · USShriners Hospitals for Children - Northern California · USThird Xiangya Hospital · CN

Funding

Fetal Tissue Engineering to Treat Spina Bifida Before BirthR01NS100761 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI WANG, AIJUN · 2017 to 2021
$1.7M
6 · The paper itself

Abstract

We have established early-gestation chorionic villus-derived placenta mesenchymal stromal cells (PMSCs) as a potential treatment for spina bifida (SB), a neural tube defect. Our preclinical studies demonstrated that PMSCs have the potential to cure hind limb paralysis in the fetal lamb model of SB

Indexed as

AnimalsApoptosisCattleCell Line, TumorCoculture TechniquesCulture Media, ConditionedExosomesFemaleGalectin 1HumansMesenchymal Stem CellsMesenchymal Stem Cell TransplantationMesodermNeural Tube DefectsNeuritesOxidative StressCulture Media, ConditionedGalectin 1LGALS1 protein, humanStaurosporineapoptosisgalectin 1mesenchymal stromal cellsneuroprotectionspina bifida

Identifiers

PMID30753093
PMCPMC6463921
OpenAlexW2911750288

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.